| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Jun 2024 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 821.24M | 858.78M | 868.21M | 944.79M | 820.54M |
| Gross Profit | 231.22M | 240.95M | 242.07M | 279.94M | 258.14M |
| EBITDA | 84.32M | 86.18M | -34.77M | -623.05M | 157.23M |
| Net Income | 129.05M | 8.16M | -80.91M | -664.34M | 100.48M |
Balance Sheet | |||||
| Total Assets | 710.90M | 685.03M | 626.81M | 601.92M | 1.23B |
| Cash, Cash Equivalents and Short-Term Investments | 35.64M | 135.18M | 48.04M | 22.72M | 631.78M |
| Total Debt | 14.57M | 24.54M | 29.90M | 41.27M | 54.40M |
| Total Liabilities | 689.65M | 793.10M | 738.62M | 636.03M | 599.75M |
| Stockholders Equity | -1.40M | -130.46M | -138.62M | -57.76M | 606.58M |
Cash Flow | |||||
| Free Cash Flow | 32.24M | 32.98M | 38.61M | 44.06M | 90.56M |
| Operating Cash Flow | 35.60M | 36.63M | 48.91M | 52.33M | 103.00M |
| Investing Cash Flow | -47.00M | -5.65M | -10.25M | -365.03M | -407.56M |
| Financing Cash Flow | -15.43M | -18.26M | -13.35M | -16.37M | 41.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$4.13B | 6.06 | 18.82% | 5.77% | 17.65% | 9.64% | |
73 Outperform | HK$4.12B | 11.85 | 11.54% | 12.09% | -9.21% | -47.87% | |
70 Outperform | HK$2.37B | ― | 17.45% | 6.30% | 21.71% | -16.77% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
59 Neutral | HK$3.61B | 27.68 | -12.90% | 4.41% | -7.01% | ― | |
56 Neutral | HK$3.29B | 18.96 | 3.94% | 11.14% | -2.22% | ― | |
49 Neutral | HK$238.63M | 2.21 | 3151.98% | ― | -4.36% | 1481.82% |